Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle.
Increased interest in development of combined gene therapy emerges from results of recent clinical trials that indicate good safety yet unexpected low efficacy of "single-gene" administration. Multiple studies showed that vascular endothelial growth factor 165 aminoacid form (VEGF165) and...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2012
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ccb99f37a0ce4bbca79c397bebfc1c9c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ccb99f37a0ce4bbca79c397bebfc1c9c |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ccb99f37a0ce4bbca79c397bebfc1c9c2021-11-18T07:15:37ZCombined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle.1932-620310.1371/journal.pone.0038776https://doaj.org/article/ccb99f37a0ce4bbca79c397bebfc1c9c2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22719942/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Increased interest in development of combined gene therapy emerges from results of recent clinical trials that indicate good safety yet unexpected low efficacy of "single-gene" administration. Multiple studies showed that vascular endothelial growth factor 165 aminoacid form (VEGF165) and hepatocyte growth factor (HGF) can be used for induction of angiogenesis in ischemic myocardium and skeletal muscle. Gene transfer system composed of a novel cytomegalovirus-based (CMV) plasmid vector and codon-optimized human VEGF165 and HGF genes combined with intramuscular low-voltage electroporation was developed and tested in vitro and in vivo. Studies in HEK293T cell culture, murine skeletal muscle explants and ELISA of tissue homogenates showed efficacy of constructed plasmids. Functional activity of angiogenic proteins secreted by HEK293T after transfection by induction of tube formation in human umbilical vein endothelial cell (HUVEC) culture. HUVEC cells were used for in vitro experiments to assay the putative signaling pathways to be responsible for combined administration effect one of which could be the ERK1/2 pathway. In vivo tests of VEGF165 and HGF genes co-transfer were conceived in mouse model of hind limb ischemia. Intramuscular administration of plasmid encoding either VEGF165 or HGF gene resulted in increased perfusion compared to empty vector administration. Mice injected with a mixture of two plasmids (VEGF165+HGF) showed significant increase in perfusion compared to single plasmid injection. These findings were supported by increased CD31+ capillary and SMA+ vessel density in animals that received combined VEGF165 and HGF gene therapy compared to single gene therapy. Results of the study suggest that co-transfer of VEGF and HGF genes renders a robust angiogenic effect in ischemic skeletal muscle and may present interest as a potential therapeutic combination for treatment of ischemic disorders.Pavel MakarevichZoya TsokolaevaAlexander ShevelevIgor RybalkinEvgeny ShevchenkoIrina BeloglazovaTatyana VlasikVsevolod TkachukYelena ParfyonovaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e38776 (2012) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Pavel Makarevich Zoya Tsokolaeva Alexander Shevelev Igor Rybalkin Evgeny Shevchenko Irina Beloglazova Tatyana Vlasik Vsevolod Tkachuk Yelena Parfyonova Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| description |
Increased interest in development of combined gene therapy emerges from results of recent clinical trials that indicate good safety yet unexpected low efficacy of "single-gene" administration. Multiple studies showed that vascular endothelial growth factor 165 aminoacid form (VEGF165) and hepatocyte growth factor (HGF) can be used for induction of angiogenesis in ischemic myocardium and skeletal muscle. Gene transfer system composed of a novel cytomegalovirus-based (CMV) plasmid vector and codon-optimized human VEGF165 and HGF genes combined with intramuscular low-voltage electroporation was developed and tested in vitro and in vivo. Studies in HEK293T cell culture, murine skeletal muscle explants and ELISA of tissue homogenates showed efficacy of constructed plasmids. Functional activity of angiogenic proteins secreted by HEK293T after transfection by induction of tube formation in human umbilical vein endothelial cell (HUVEC) culture. HUVEC cells were used for in vitro experiments to assay the putative signaling pathways to be responsible for combined administration effect one of which could be the ERK1/2 pathway. In vivo tests of VEGF165 and HGF genes co-transfer were conceived in mouse model of hind limb ischemia. Intramuscular administration of plasmid encoding either VEGF165 or HGF gene resulted in increased perfusion compared to empty vector administration. Mice injected with a mixture of two plasmids (VEGF165+HGF) showed significant increase in perfusion compared to single plasmid injection. These findings were supported by increased CD31+ capillary and SMA+ vessel density in animals that received combined VEGF165 and HGF gene therapy compared to single gene therapy. Results of the study suggest that co-transfer of VEGF and HGF genes renders a robust angiogenic effect in ischemic skeletal muscle and may present interest as a potential therapeutic combination for treatment of ischemic disorders. |
| format |
article |
| author |
Pavel Makarevich Zoya Tsokolaeva Alexander Shevelev Igor Rybalkin Evgeny Shevchenko Irina Beloglazova Tatyana Vlasik Vsevolod Tkachuk Yelena Parfyonova |
| author_facet |
Pavel Makarevich Zoya Tsokolaeva Alexander Shevelev Igor Rybalkin Evgeny Shevchenko Irina Beloglazova Tatyana Vlasik Vsevolod Tkachuk Yelena Parfyonova |
| author_sort |
Pavel Makarevich |
| title |
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| title_short |
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| title_full |
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| title_fullStr |
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| title_full_unstemmed |
Combined transfer of human VEGF165 and HGF genes renders potent angiogenic effect in ischemic skeletal muscle. |
| title_sort |
combined transfer of human vegf165 and hgf genes renders potent angiogenic effect in ischemic skeletal muscle. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2012 |
| url |
https://doaj.org/article/ccb99f37a0ce4bbca79c397bebfc1c9c |
| work_keys_str_mv |
AT pavelmakarevich combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT zoyatsokolaeva combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT alexandershevelev combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT igorrybalkin combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT evgenyshevchenko combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT irinabeloglazova combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT tatyanavlasik combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT vsevolodtkachuk combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle AT yelenaparfyonova combinedtransferofhumanvegf165andhgfgenesrenderspotentangiogeniceffectinischemicskeletalmuscle |
| _version_ |
1718423757041696768 |